Stock data
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported net income of -US$78.54M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$85.31M | -US$78.54M | — |
| 2024 | — | — | -US$48.72M | -US$40.21M | — |
| 2023 | — | — | -US$45.08M | -US$44.60M | — |
| 2022 | US$0.00M | — | -US$39.84M | -US$42.35M | — |
| 2021 | US$0.88M | — | -US$55.99M | -US$45.64M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$35.04M | — |
| 2026-03-31 | — | -US$22.97M | — |
| 2025-12-31 | — | -US$20.55M | — |
| 2025-09-30 | — | -US$23.34M | — |
| 2025-06-30 | — | -US$17.66M | — |
| 2025-03-31 | — | -US$16.98M | — |
| 2024-12-31 | — | -US$9.53M | — |
| 2024-09-30 | — | -US$13.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.